Microbiology
-
In vitro evaluation of therapeutic antibodies against a SARS-CoV-2 Omicron B.1.1.529 isolate
This article has 4 authors:Reviewed by ScreenIT
-
RG203KR Mutations in SARS-CoV-2 Nucleocapsid: Assessing the Impact Using a Virus-Like Particle Model System
This article has 8 authors:Reviewed by ScreenIT
-
Omicron variant escapes therapeutic mAbs contrary to eight prior main VOC
This article has 5 authors:Reviewed by ScreenIT
-
An in vitro and in vivo approach for the isolation of Omicron variant from human clinical specimens
This article has 17 authors:Reviewed by ScreenIT
-
The altered entry pathway and antigenic distance of the SARS-CoV-2 Omicron variant map to separate domains of spike protein
This article has 20 authors:Reviewed by ScreenIT
-
Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters
This article has 16 authors:Reviewed by ScreenIT
-
Subgenomic SARS-CoV-2 replicon and reporter replicon cell lines enable ultrahigh throughput antiviral screening and mechanistic studies with antivirals, viral mutations or host factors that affect COVID-19 replication
This article has 15 authors:Reviewed by ScreenIT
-
SARS-CoV-2 Omicron-B.1.1.529 Variant leads to less severe disease than Pango B and Delta variants strains in a mouse model of severe COVID-19
This article has 15 authors:Reviewed by ScreenIT
-
Intranasal inhibitor broadly blocks SARS-CoV-2 including recent highly immunoevasive Omicron subvariants
This article has 23 authors:Reviewed by ScreenIT
-
Effect of nebulised BromAc ® on rheology of artificial sputum: relevance to muco-obstructive respiratory diseases including COVID-19
This article has 5 authors:Reviewed by ScreenIT